Prot# ION-682884-CS2: A Phase 3 Global, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ION-682884 in Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

Project: Research project

Project Details

StatusActive
Effective start/end date6/26/206/26/26

Funding

  • Pharmaceutical Research Associates, Inc. (Prot# ION-682884-CS2 // Prot# ION-682884-CS2)
  • Ionis Pharmaceuticals, Inc. (Prot# ION-682884-CS2 // Prot# ION-682884-CS2)